Inhibition of aflatoxin B1 mutagenesis in salmonella typhimurium and DNA damage in cultured rat and human tracheobronchial tissues by ellagic acid

Carcinogenesis

Volumn 8, Issue 11, 1987, Pages 1651-1656

  Mandal, Swapna ^a   Ahuja, Arvind ^a   Shivapurkar, Narayan M ^a   Cheng, Shu Jun ^b   Groopman, John D ^c   Stoner, Gary D ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b INSTITUTE OF CANCER RESEARCH   (China)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; ELLAGIC ACID; AFLATOXIN; BENZOPYRAN DERIVATIVE; DNA; GLUTATHIONE TRANSFERASE;

ANIMAL CELL; CELL CULTURE; DNA ADDUCT; HUMAN; LIVER MICROSOME; MUTAGENESIS; MUTATION INHIBITION; NONHUMAN; SALMONELLA TYPHIMURIUM; ANIMAL; ARTICLE; BIOSYNTHESIS; BRONCHUS; DNA DAMAGE; DRUG EFFECT; METABOLISM; MUTATION; RAT; TRACHEA;

AFLATOXIN B1; AFLATOXINS; ANIMAL; BENZOPYRANS; BRONCHI; CELLS, CULTURED; DNA; DNA DAMAGE; ELLAGIC ACID; GLUTATHIONE TRANSFERASE; HUMAN; MUTATION; RATS; SALMONELLA TYPHIMURIUM; SUPPORT, U.S. GOV'T, P.H.S.; TRACHEA;

EID: 0023525752     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/8.11.1651     Document Type: Article

References (52)

1. Hirayama, T. (1979) Diet and cancer. Nutr. Cancer, 1, 67-81.
2. Mettlin, C., Graham, S., Priore, R., (1980) Diet and cancer of the esophagus. Nutr. Cancer, 2, 143-147.
3. Palmer, S. and Bakshi, K. (1983) Diet, nutrition, and cancer interim dietary guidelines. J. NatL Cancer Inst., 70, 1151-1170.
4. Wattenberg, L.W. (1985) Chemoprevemion of cancer. Cancer Res., 45, 1 -8.
5. Bate-Smith, E.C. (1959) Plant phenolics in foods. In Fairbaim, J.W. (ed.). The Pharmacology of Plant Phenolics. Academic Press, New York, pp. 133-147.
6. Wood, A.W., Huang, M.-T., Chang, R.L., Newmark, H.L., Lehr, R.E., Yagi, H., Sayer J.M., Jerina, D.M. and Conney, A.H. (1982) Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid. Proc. Natl. Acad. Sri. USA, 79, 5513-5517.
7. Wood, A.W., Huang, M.-T., Chang, R.L., Newmark, H.L., Lehr, R.E., Yagi, H., Sayer J.M., Jerina, D.M. and Conney, A.H. (1982) Extremely facile reaction between the ultimate carcinogen benzo(a]pyrene-7,8-diol 9,10-epoxide and ellagic acid. J. Am. Chem. Soc., 104, 5562-5564.
8. Sims, P. (1980) The metabolic activation of chemical carcinogens. Br. Med. Bull., 36, 11-18.
9. Kapitulnik J., Wislocki, P.G., Levin, W., Yagi, H., Jerina, D.M. and Conney, A.H. (1978) Tumorigemcity studies with diol-epoxidcs of benzo(a]pyrene which indicate that (± Hranr-7$,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetra-hydrobenzo[a]pyrene is an ultimate carcinogen in newborn mice. Cancer Res., 38, 354 - 358.
10. Del Tito, B.J. Jr, Mukhtar, H. and Bickers, D.R. (1983) Inhibitioa of epidermal metabolism and DNA-binding of benzo(a]pyrene by ellagic acid. Biochan. Biophys. Res. Common., 114, 388-394.
11. Dixit, R., Teel, R.W., Daniel, F.B. and Stoner, G.D. (1985) Inhibition of benzo(a]pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid. Cancer Res., 45, 2951-2956.
12. Dixi LR., Ted, R.W., Babcock, M.S., Kim, K. and Stoner, G.D. (1986) Ellagic acid: an inhibitor of DNA binding of benzo[a]pyrene in cultured mouse and human lung tissues. In Cooke, M. and Detmis, AJ. (eds), Potynudear Aromatic Hydrocarbons. Chemistry, Characterization and Carcinogenesis, Balelle Press, Columbus, OH, USA, pp. 239 -250.
13. Lesca, P. (1983) Protective effects of ellagic acid and other plant phenols on bcnzo(a]pyrene-induced neoplasia in mice. Carcinogenesis, 4, 1651-1653.
14. Chang, R.L., Huang, M.-T., Wood, A.W., Wong, C.-Q., Newmark, H.L., Yagi, H., Sayer J.M., Jerina, D.M. and Conney, A.H. (1985) Effect of ellagic acid and hydroxylated flavonoids on the tumorigenicity of benzo(a]pyrene and (±)-7(),8a-dihydroxy-9ar, 10a-epoxy-7,8,9,10-tetrahydrobenzo(a]pyrene on mouse skin and in the newborn mouse. Carcinogenesis, 6, 1127-1133.
15. Mukhtar, H., Das, M., (1984) Protection against 3-methylcholanthrene-induced skin tumorigenesis in BALB/c mice by ellagic acid. Biochem. Biophys. Res. Common., 119, 751-757.
16. Mukhtar, H., Das, M. and Bickers, D. (1986) Inhibition of 3-methylcholan-thrcne-induced skin tumorigenicity in BALB/c mice by chronic oral feeding of trace amounts of ellagic acid in drinking water. Cancer Res., 46, 2262 -2265.
17. Smart, R.C., Huang, M.-T., Chang, R.L., Sayer, J.M., Jerina, D.M., Wood, A.W. and Conney, A.H. (1986) Effect of ellagic acid and 3-0- decylellagic acid on the formation of benzo[a]pyrene-derived DNA adducts in vivo and on the tumorigenicity of 3-methylcholanthrene in mice. Carcinogenesis, 7, 1669-1675.
18. Busby, W.F., Jr. and Wogan, G.N. (1984) Aflatoxins. In Searle.C.E. (ed.), Chemical Carcinogens. American Chemical Society, Washington, DC, 2nd edn, pp. 945-1136.
19. Peers, F.G. and Linsell, C.A. (1973) Dietary aflatoxins and liver cancer: a population based study in Kenya. Br. J. Cancer, 27, 473-484.
20. Sorenson, W.G., Simpson J.P., Peach, MJ., Thedell, T.D. and Olenchock, S.A. (1981) Aflatoxin in respirable com dust particles. J. Toxicol Environ. Health, 1, 669 - 672.
21. Hayes, R.B., Van Nieuwenhuize J.P., Raatgever J.W. and TenKate, FJ.W. Aflatoxin exposures in the industrial setting: an epidemiological study of mortality. FtL Chem. Toxicol., 22, 39-43.
22. Autrup, H., Essigmann J.M., Croy, R.G., Trump, B.F., Wogan, G.N. and Harris, C.C. (1979) Metabolism of aflatoxin B, and identification of the major aflatoxin By — DNA adducts formed in cultured human bronchus and colon. Cancer Res., 39, 694-698.
23. Stoner, G.D., Daniel, F.B., Schenck, K.M., Schut, H.A.J., Sandwisch, D.W. and Gohara A.F. (1982) DNA binding and adduct formation of aflatoxin B, in cultured human and animal tracheobronchial and bladder tissues. Carcinogenesis, 3, 1345-1348.
24. Coulombe, R.A., Jr., Wilson, D.W., Hsieh, D.P.H., Plopper, C.G. and Serabjit-Singh, C.J. (1986) Metabolism of aflatoxin B, in the upper airways of the rabbit: role of the non-ciliated tracheal epithelial cell. Cancer Res., 46, 4091 - 4096.
25. Wang, T.V. and Cemtti, P.A. (1979) Formation and removal of aflatoxin-induced DNA lesions in epithelioid human lung cells. Cancer Res., 39, 5165-5170.
26. Dickens, F., Jones, H.E.H. and Waynforth, H.B. (1966) Oral, subcutaneous, and intratracheal administration of carcinogenic lactones and related substances: the intratracheal administration of cigarette tar in the rat. Br. J. Cancer. 20. 134-144.
27. Stoner, G.D., Conran, P.B., Greisiger, E.A., Stober J., Morgan, M. and Pereira, M.A. (1986) Comparison of two routes of chemical administration on the lung adenoma response in strain A/J mice. Toxicol. Appl. Pharmacol., 82, 19-31.
28. Maron, D.M. and Ames, B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
29. Ames, B.N., McCann J. and Yamasaki, E. (1975) Methods for detecting carcinogens and mutagens with the SoImozKflo/mammalian-micTosome mutagenicity test. Mum. Res., 31, 347-364.
30. Trump, B.F., McDowell, E., Barrett, L., Frank, A. and Harris, C.C. (1974) Studies of ultrastructure, cytochemistry and organ culture of human trachea] epithelium. In Karbe.E. and ParkJ.J. (eds), Experimental Lung Cancer. Springer, New York, pp. 548-563.
31. Leibovitz, A. (1963) The growth and maintenance of tissue cell cultures in free gas exchange with the atmosphere. Am. J. Hyg., 78, 173-180.
32. Stoner, G.D., Pettis, W., Haugen, A., Jackson, F. and Harris, C.C. (1981) Explant culture of rat esophagus in a chemically defined medium. In Vitro, 17, 681-688.
33. Stoner, G.D., Daniel, F.B., Schenck, K.M., Schut, H.A.J., Goldblatt, P.J. and Sandwisch, D.W. (1982) Metabolism and DNA binding of benzo(a]pyrene in cultured human bladder and bronchus. Carcinogenesis, 3, 195-201
34. Kirby, K.S. (1965) Isolation and characterization of ribosomal ribonucleic acid. Biodiem. J., 96, 266-269.
35. Teel, R.W., Dixit, R. and Stoner, G.D. (1985) The effect of ellagic acid on the uptake, persistence, metabolism and DNA-binding of benzo[a]pyrene in cultured explants of strain A/J mouse lung. Carcinogenesis, 6, 391-395.
36. Teel, R.W., Stoner, G.D., Babcock, M.S., Dixit, R. and Kim, K. (1986) Benzo-[ajpyrcne metabolism and DNA-binding in cultured explains of human bronchus and in monolayer cultures of human bronchia] epithelial cells treated with ellagic acid. Cancer Detec. Prev., 9, 59-66.
37. Bate-Smith, E.C. (1972) Detection and determination of ellagitannins. Phytochemistry, 11, 1153-1156.
38. Cliffton, E.E. (1967) The effects of ellagic acid on the coagulation mechanisms and on traumatic bleeding. Am. J. Med. Sci., 254, 483-490.
39. Botti, R.E. and Ratnoff, O.D. (1964) Studies on the pathogenesis of thrombosis: an experimental ‘hypercoagulable’ state induced by the intravenous injection of ellagic acid. J. Lab. Clin. Med., 64, 385-398.
40. Bhaigava, U.C. and Westfall, B.A. (1968) Antitumor activity of Juglans nigra (black walnut) extractives. J. Pham. Sci., 57, 1674-1677.
41. Mukhtar, H., Del Tito, B.J., Jr., Marcelo, C.L., Das, M. and Bickers, D.R. Ellagic acid: a potent naturally occurring inhibitor of benzo[a]pyrcne metabolism and its subsequent glucuronidation, sulfation and covalent binding to DNA in cultured BALB/c mouse keratinocytes. Carcinogenesis, 5, 1565-1571.
42. Das, M., Bickers, D.R. and Mukhtar, H. (1985) Effect of ellagic acid on hepatic and pulmonary xenobiotic metabolism in mice: studies on the mechanism of its anticarcinogenic action. Carcinogenesis, 6, 1409-1413.
43. Kensler, T.W., Egner, P.A., Trush, M.A., Bueding.E. and Groopman J.D. Modification of aflaloxin B, binding to DNA in vivo in rats fed phenolic antioxidants, ethoxyquin and a dithiothione. Carcinogenesis, 6, 759-763.
44. Gurtoo, H.L. and Bejba, N. (1974) Hepatic microsomal mixed function oxygenase: enzyme multiplicity for the metabolism of carcinogens to DNA-binding metabolites. Biochem. Biophys. Res. Common., 61, 735-742.
45. Swenson, D.H., Lin J.K., Miller, E.C. and Miller J.A. (1977) Aflaloxin Bp 2,3-oxide as a probable intermediate in the covalent binding of aflaloxins B, and Bj to rat liver DNA and ribosomal RNA in vfvo. Cancer Res.,37, 172-181.
46. Essigmann J.M., Croy, R.G., Nadzan, W.F., Busby, V.N., Jr., Reinhold, V.N., Buchi, G. and Wogan, G.N. (1977) Structural identification of the major DNA adduct formed by aflatoxin B in vitro. Proc. NmL Acad. Sci. USA, 74, 1870-1874.
47. Croy, R.G., Essigmann J.M., Reinhold, V.N. and Wogan, G.N. (1978) Identification of the principal aflatoxin B[— DNA adduct formed in vivo in rat liver. Proc. NmL Acad. Sci. USA, 74, 1745-1749.
48. Croy, R.G. and Wogan, G.N. (1981) Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin Bp Cancer Res., 41, 197 -203
49. Dvorackova, I. (1976) Aflatoxin inhalation and alveolar cell carcinoma. Br. Med. J., 1, 691.
50. Dvorackova, I., Stora, C. and Ayraud, N. (1981) Evidence for aflatoxin B in two cases of lung cancer in men. J. Cancer Res. Clin. Oncol., 100, 221-224.
51. Mandal, S., Shivapurkar, N., Superczynsld, M. and Stoner, G.D. (1986) Inhibition of methylbenzylnitrosamine-induced esophageal tumors in rats by ellagic acid. Proc. Am, Assoc. Cancer Res., 27, 124.
52. Dixit, R. and Gold, B. (1986) Inhibition of N-methyl-N-nitiosourea-induced